Aruna Raghavachar

Treatment of Aplastic Anemia with Antilymphocyte Globulin and Methylprednisolone with or without Cyclosporine

Norbert Frickhofen, J. P. Kaltwasser, Hubert Schrezenmeier et al. · New England Journal of Medicine · 1991 · 423 citations · Full text

Pharmacy, Hematology, Pharmacotherapy +12

Positron Emission Tomography–Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial

Ulrich Dührsen, Stefan Müller, Bernd Hertenstein et al. · Journal of Clinical Oncology · 2018 · 251 citations · Full text

Medicine, Oncology, Chemotherapy +14

Impact of <i>IDH1</i> R132 Mutations and an <i>IDH1</i> Single Nucleotide Polymorphism in Cytogenetically Normal Acute Myeloid Leukemia: SNP rs11554137 Is an Adverse Prognostic Factor

Katharina Wagner, Frédérik Damm, Gudrun Göhring et al. · Journal of Clinical Oncology · 2010 · 240 citations

Life Sciences, Genetics, Molecular Genetics +16

Prospective Randomized Multicenter Study Comparing Cyclosporin Alone Versus the Combination of Antithymocyte Globulin and Cyclosporin for Treatment of Patients With Nonsevere Aplastic Anemia: A Report From the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party

Judith Marsh, Hubert Schrezenmeier, Osman İlhan et al. · Blood · 1999 · 211 citations

Pharmacy, Hematology, Pharmacotherapy +13

Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia

Felicitas Thol, Frédérik Damm, Katharina Wagner et al. · Blood · 2010 · 183 citations · Full text

Life Sciences, Genetics, Oncology +16